H+E Pharma GmbH and its subsidiary S-Tec GmbH have been sold to BW Water GmbH, enhancing the latter's capabilities in the ultrapure water market.

Target Information

H+E Pharma GmbH, along with its subsidiary S-Tec GmbH, has been strategically advised by Saxenhammer exclusively during its sale to BW Water GmbH. This transaction also included the transfer of property to the buyer. H+E Pharma and S-Tec specialize in the production and distribution of ultrapure water systems primarily for the pharmaceutical and semiconductor industries. S-Tec focuses on plant engineering, whereas H+E Pharma is responsible for the maintenance of these systems. Both companies are based in Silicon Saxony, in Klipphausen, close to Dresden.

BW Water, headquartered in Stuttgart, is part of the BW Group, which is based in Singapore. The company is internationally recognized as a market leader in providing water and wastewater solutions for both industrial and municipal markets. BW Water handles the planning, construction, and service of facilities related to water and wastewater treatment.

Industry Overview in Germany

The water treatment industry in Germany is experiencing significant growth as a result of increasing regulations and the ever-growing demand for clean water. With industrial applications ranging from pharmaceuticals

View Source

Similar Deals

Ancala Solandeo and Hausheld

2025

Merger Multiline Utilities Germany
Kanalservice Gruppe Kanalservice Braunen

2022

Merger Sewage Treatment Facilities Germany
Wilo SE ABIONIK Group GmbH

2020

Merger Sewage Treatment Facilities Germany
Schneider Weisse Bischofshof and Weltenburger

2027

Merger Brewers (NEC) Germany
Montrose Environmental Group, Inc. Montrose Environmental Group Denmark

2026

Merger Water & Related Utilities (NEC) Denmark
Vodafone Skaylink

2026

Merger Cloud Computing Services Germany

BW Water GmbH

invested in

H+E Pharma GmbH and S-Tec GmbH

in 2023

in a Merger deal

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert